Miromatrix Medical


Developer of biologic, transplantable organs using perfusion-based decellularization of porcine organs and subsequent perfusion recellularization with human cells. Focused on engineering kidneys and livers and an extracorporeal bioengineered liver support system. Founded from academic research in 2009, the organization operates preclinical large-animal programs, has completed early clinical work with decellularized matrix products, and holds an extensive global patent portfolio.

Industries

Biotechnology Research

Nr. of Employees

medium (51-250)

Miromatrix Medical

Eden Prairie, Minnesota, United States


Patents

Methods of recellularizing a tissue or organ for improved transplantability

US-12522802-B2

View Details

Fistula filler and deployment system

US-12263275-B2

View Details

Methods of recellularizing a tissue or organ for improved transplantability

US-12084677-B2

View Details

Use of resected liver serum for whole liver-engineering

US-12076461-B2

View Details

Use of perfusion decellularized liver for islet cell recellularization

US-11452797-B2

View Details

Methods of recellularizing a tissue or organ for improved transplantability

US-11414644-B2

View Details
View All Patents

Products

Bioengineered kidney grafts

Transplantable kidney grafts created by perfusion decellularization of porcine kidneys and perfusion recellularization with human cells for eventual clinical transplantation.

Bioengineered liver grafts

Transplantable liver grafts produced by perfusion decellularization of porcine livers followed by recellularization with hepatocytes and vascular cells; demonstrated sustained perfusion and liver function in large-animal models.

Extracorporeal bioengineered liver support system

An integrated extracorporeal system combining a single-use bioengineered liver graft with an external blood-circuit intended to provide temporary liver support for acute liver failure patients.

Expertise Areas

  • Organ decellularization and scaffold engineering
  • Perfusion-based recellularization and organ repopulation
  • Bioengineered organ development (kidney and liver focus)
  • Preclinical large-animal transplantation studies
  • Show More (3)

Key Technologies

  • Perfusion decellularization
  • Perfusion recellularization
  • Bioreactor-based organ culture
  • Vascular re-endothelialization and revascularization
  • Show More (4)

News & Updates

Presentation at a regenerative medicine industry meeting.

Presentation featuring kidney program representatives.

Preclinical study reporting filtration function of decellularized porcine kidney grafts repopulated with human cells in pig models.

Study on manufacturing and functional characterization of bioengineered liver grafts for extracorporeal assistance.

Report of sustained perfusion of re-endothelialized kidney grafts in a human-scale animal model.

Article describing re-endothelialization approaches for decellularized liver scaffolds.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.